GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2951 - 2975 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 3 4 mild
G47566FL
68
IgG Patient 1 22 moderate
G17140UR
67
IgM Patient 1 22 moderate
G25559RS
67
IgG Patient 1 6 moderate
G94576MN
67
IgM Patient 2 15 mild
G90562PB
67
IgG Patient 2 3 mild
G39213VZ
67
IgM Patient 2 3 mild
G32611KT
67
IgG Patient 3 -180 mild
G36191CD
67
IgM Patient 3 -180 mild
G00048MO
67
IgM Patient 3 -180 mild
G10789DJ
67
IgG Patient 3 4 mild
G32699RJ
67
IgG Patient 3 4 mild
G47548GA
67
IgG Patient 3 4 mild
G72739GY
67
IgG Patient 3 4 mild
G86156UJ
67
IgG Patient 4 12 mild
G38488WF
67
IgG Patient 4 12 mild
G89993FE
67
IgM Patient 1 10 moderate
G10133VD
66
IgM Patient 1 22 moderate
G16579HJ
66
IgG Patient 1 6 moderate
G47362BJ
66
IgM Patient 1 6 moderate
G17140UR
66
IgG Patient 2 24 mild
G82204SH
66
IgM Patient 2 15 mild
G61399NC
66
IgG Patient 2 3 mild
G94435QH
66
IgG Patient 3 11 mild
G32699RJ
66
IgG Patient 3 11 mild
G86156UJ
66

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024